23.81k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
The fight against COVID19 | -1.49% | - | - | - |
^GSPC | -1.04% | -3.55% | +23.74% | +5296.61% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 146.41 | -2.12 | -1.43% | 12:15 pm GMT-4 | 2.98M | 7.63M | 352.82B |
ABBV | AbbVie Inc. | 166.83 | -0.97 | -0.58% | 12:14 pm GMT-4 | 1.77M | 5.62M | 295.40B |
PFE | Pfizer Inc. | 25.525 | -0.75 | -2.84% | 12:15 pm GMT-4 | 18.95M | 42.21M | 144.54B |
SNY | Sanofi | 49.46 | +2.85 | +6.11% | 12:14 pm GMT-4 | 4.49M | 1.93M | 125.38B |
REGN | Regeneron Pharmaceuticals, Inc. | 889.61 | -16.93 | -1.87% | 12:14 pm GMT-4 | 237.92k | 464.59k | 97.65B |
GSK | GSK plc | 40.9597 | +0.10 | +0.24% | 12:14 pm GMT-4 | 1.44M | 3.48M | 83.68B |
GILD | Gilead Sciences, Inc. | 65.53 | -1.55 | -2.31% | 12:15 pm GMT-4 | 4.22M | 7.19M | 81.71B |
TAK | Takeda Pharmaceutical Company Limited | 13.115 | -0.11 | -0.87% | 12:13 pm GMT-4 | 701.05k | 1.83M | 41.56B |
MRNA | Moderna, Inc. | 105.06 | -3.79 | -3.48% | 12:15 pm GMT-4 | 1.40M | 3.78M | 40.23B |
BNTX | BioNTech SE | 86.645 | -1.44 | -1.64% | 12:14 pm GMT-4 | 170.85k | 605.02k | 20.88B |
VIR | Vir Biotechnology, Inc. | 7.62 | -0.42 | -5.22% | 12:14 pm GMT-4 | 261.63k | 1.05M | 1.04B |
NVAX | Novavax, Inc. | 3.96 | -0.19 | -4.58% | 12:15 pm GMT-4 | 1.23M | 7.22M | 554.21M |
INO | Inovio Pharmaceuticals, Inc. | 10.004 | -0.16 | -1.54% | 12:09 pm GMT-4 | 65.29k | 484.32k | 259.17M |
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
Regeneron (REGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.